You Position: Home > Paper
Clinical and angiographic follow-up study of sirolimus-eluting stent for treatment of in-stent restenosis
( views:82, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 5
- DOI:
- No doi available
- Key Word:
- stent;restenosis;drug-eluting stent;sirolimus
Abstract： @@ With widespread performance of coronary artery stenting, the number of in-stent restenosis (ISR) has increased in recent years. How to treat ISR effectively has been a great challenge in the field of cardiology. Recently, some notable clinical trials have confirmed that sirolimus-eluting stents (SESs) (CYPHERTM, Cordis, J&J Inc, USA) reduce ISR rate dramatically. So far, there have been few reports on the efficacy of using SESs to treat ISR.1,2 So, we used SESs to treat 27 patients with ISR and followed up for at least six months.
- [1]Degertekin M,Vos J,Serruys PW,etc.Sirolimus-eluting stent for treatment of complex in-stent restenosis. The first clinical experience.[J].2003,41(2).
- [2]R, Kornowski,M K, Hong,F O, Tio,etc.In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.[J].1998,31(1).
- [3]R, Hoffmann,G S, Mintz,G R, Dussaillant,etc.Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study.[J].1996,94.
- [4]Roxana Mehran,George Dangas,Andrea Abizaid,etc.Angiographic Patterns of In-Stent RestenosisClassification and Implications for Long-Term Outcome[J].1999,100(18).
- [5]Bernhard Reimers,Issam Moussa,Tatsuro Akiyama,etc.Long-Term Clinical Follow-Up After Successful Repeat Percutaneous Intervention for Stent Restenosis[J].1997,30(1).